American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Guardant Health, Inc. Common Stock

GH Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

GH historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of GH by members of U.S. Congress

Politician Type Traded
Sheldon Whitehouse Senate / D Purchase $1,001 - $15,000 Nov 21, 2025
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Feb 28, 2022
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Jan 13, 2022
Ro Khanna House / D Sale None N/A
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Dec 22, 2021
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov 02, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Oct 22, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Oct 05, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Jul 14, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 May 01, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Apr 27, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Feb 14, 2020
GH Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
GH Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
GH Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in GH holdings by institutional investors

Insider Trading

Quarterly net insider trading by GH's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $180,000 Jul 20, 2026 Issue: Medicare/Medicaid Health Issues
  • $241,000 Apr 20, 2026 Issue: Medicare/Medicaid Health Issues
  • $741,000 Jan 20, 2026 Issue: Medicare/Medicaid Health Issues
  • $241,000 Oct 17, 2025 Issue: Medicare/Medicaid Health Issues
  • $241,000 Jul 27, 2025 Issue: Medicare/Medicaid Health Issues
  • $241,000 Apr 21, 2025 Issue: Medicare/Medicaid Health Issues
  • $260,000 Jan 08, 2025 Issue: Medicare/Medicaid Health Issues
  • $260,000 Oct 20, 2024 Issue: Health Issues Medicare/Medicaid
  • $260,000 Aug 12, 2024 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jul 15, 2024 Issue: Budget/Appropriations Health Issues
  • $260,000 Jan 19, 2024 Issue: Health Issues Medicare/Medicaid
  • $260,000 Oct 19, 2023 Issue: Health Issues Medicare/Medicaid
  • $260,000 Jul 20, 2023 Issue: Health Issues Medicare/Medicaid
  • $220,000 Jan 19, 2023 Issue: Veterans Labor Issues/Antitrust/Workplace Health Issues Medicare/Medicaid
  • $220,000 Oct 20, 2022 Issue: Veterans Labor Issues/Antitrust/Workplace Health Issues Medicare/Medicaid
  • $220,000 Jul 20, 2022 Issue: Labor Issues/Antitrust/Workplace Health Issues Medicare/Medicaid
  • $220,000 Apr 20, 2022 Issue: Health Issues Medicare/Medicaid
  • $200,000 Jan 21, 2022 Issue: None
  • $200,000 Oct 19, 2021 Issue: None
  • $200,000 Jul 20, 2021 Issue: None
  • $200,000 Apr 21, 2021 Issue: None
  • $160,000 Jan 20, 2021 Issue: None
  • $160,000 Oct 20, 2020 Issue: None
  • $180,000 Jul 20, 2020 Issue: None
  • $167,500 Apr 20, 2020 Issue: None
  • $70,000 Jan 20, 2020 Issue: None
  • $70,000 Oct 20, 2019 Issue: Medicare/Medicaid Health Issues
  • $60,000 Jul 22, 2019 Issue: Veterans Health Issues Medicare/Medicaid
  • $60,000 Apr 17, 2019 Issue: Veterans Health Issues
  • $60,000 Jan 18, 2019 Issue: Budget/Appropriations Health Issues Veterans
  • $60,000 Oct 18, 2018 Issue: Health Issues
  • $60,000 Jul 20, 2018 Issue: Health Issues
  • $60,000 Apr 20, 2018 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jan 22, 2018 Issue: Health Issues Medicare/Medicaid
  • $60,000 Oct 20, 2017 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jul 19, 2017 Issue: Health Issues Medicare/Medicaid
  • $60,000 Apr 20, 2017 Issue: Health Issues Medicare/Medicaid
  • $20,000 Jan 18, 2017 Issue: Health Issues
Revolving Door

Former government officials who have lobbied for GH

27 former government officials from 18 congressional offices at 7 lobbying firms have lobbied for GH, most recently Jul 21, 2026.

  • John B. Shadegg
    Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg Formerly with John B. Shadegg · TODD STRATEGY GROUP · Jul 21, 2026
  • Daniel Todd Senate Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid Formerly Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Ad · TODD STRATEGY GROUP · Jul 21, 2026
  • Nicholas Uehlecke House Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee Formerly Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legis · TODD STRATEGY GROUP · Jul 21, 2026
  • Jennifer Leib Senate Fellow, Senate Committee on Health, Education, Labor, and Pensions Formerly Fellow, Senate Committee on Health, Education, Labor, and Pensions · IPOLICY SOLUTIONS · Jul 16, 2026
  • Nicholas Bath Senate Health Policy Director of the U.S. Senate Committee on Health, Education, Labor and Pensions Formerly Health Policy Director of the U.S. Senate Committee on Health, Education, Labor · MANATT, PHELPS, AND PHILLIPS · Jul 21, 2025
  • Timothy H. Bishop
    Edward Waters House Legislative Assistant to Rep. Timothy Bishop (NY-01) Formerly with Timothy H. Bishop · MANATT, PHELPS, AND PHILLIPS · Jul 21, 2025
  • Stephen Weyler House New Health and Labor Fellow, U.S. House of Representatives, Committee on Education & Labor (2019) Formerly Health and Labor Fellow, U.S. House of Representatives, Committee on Education & · INVARIANT LLC · Jul 17, 2025
  • Bill Cassidy
    Christopher Gillott Senate New Sen. Bill Cassidy: Deputy Chief of Staff, Policy (2018-2021); Legislative Dir (2013-2021); Sr Legislative Asst (2013); Rep. Bobby Jindal: Leg. Dir (2007-2008); Sr Legislative Asst (2005-2007); Sen. Kay Bailey Hutchison: Leg Aide (2003-2005) Formerly with Bill Cassidy · INVARIANT LLC · Jul 17, 2025
See all 27 on the Revolving Door dashboard
Corporate Lobbying

GH Estimated quarterly lobbying spending

Revenue Breakdown

GH Revenue by Segment or Geography

By Segment
By Geography
GH Income Statement
GH Balance Sheet
GH Cash Flow
U.S. Patents

New GH patent grants

  • Patent Title: Systems and methods to detect rare mutations and copy number variation Sep. 15, 2026
  • Patent Title: Microsatellite instability detection in cell-free dna Aug. 25, 2026
  • Patent Title: Microsatellite instability detection in cell-free dna Aug. 25, 2026
  • Patent Title: Population based treatment recommender using cell free dna Aug. 11, 2026
  • Patent Title: Population based treatment recommender using cell free dna Aug. 11, 2026
  • Patent Title: Identification of somatic or germline origin for cell-free dna Aug. 04, 2026
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Jul. 28, 2026
  • Patent Title: Microsatellite instability detection in cell-free dna Jul. 28, 2026
  • Patent Title: Computational modeling of loss of function based on allelic frequency Jun. 23, 2026
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Jun. 23, 2026
  • Patent Title: Compositions and methods for analyzing cell-free dna in methylation partitioning assays Jun. 16, 2026
  • Patent Title: Compositions and methods for isolating cell-free dna May. 19, 2026
  • Patent Title: Systems and methods to detect rare mutations and copy number variation May. 12, 2026
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Apr. 21, 2026
  • Patent Title: Methods and applications of gene fusion detection in cell-free dna analysis Apr. 14, 2026
  • Patent Title: Cancer evolution detection and diagnostic Apr. 07, 2026
  • Patent Title: Methods for fragmentome profiling of cell-free nucleic acids Mar. 31, 2026
  • Patent Title: Methods for early detection of cancer Mar. 10, 2026
  • Patent Title: Methods for early detection of cancer Mar. 10, 2026
  • Patent Title: Genetic variant detection based on merged and unmerged reads Mar. 03, 2026
  • Patent Title: Methods and systems for analyzing nucleic acid molecules Mar. 03, 2026
  • Patent Title: Computer architecture for identifying lines of therapy Feb. 10, 2026
  • Patent Title: Methods and systems for analyzing nucleic acid molecules Feb. 10, 2026
  • Patent Title: Network bandwidth architecture for bioinformatics system Dec. 16, 2025
  • Patent Title: Computer architecture for generating an integrated data repository Nov. 18, 2025
  • Patent Title: Sequencing methods with partitioning Nov. 11, 2025
  • Patent Title: Data processing abstraction for high performance computing systems Oct. 28, 2025
  • Patent Title: Single namespace for high performance computing system Oct. 28, 2025
  • Patent Title: Methods and systems for detecting genetic variants Oct. 07, 2025
  • Patent Title: Methods and systems for analyzing nucleic acid molecules Sep. 30, 2025
  • Patent Title: Normalizing tumor mutation burden Aug. 12, 2025
  • Patent Title: Methods and systems for analyzing nucleic acid molecules Jul. 15, 2025
  • Patent Title: Microsatellite instability detection in cell-free dna Jul. 01, 2025
  • Patent Title: Methods for multi-resolution analysis of cell-free nucleic acids Jun. 24, 2025
  • Patent Title: Display screen or portion thereof with graphical user interface Jun. 03, 2025
  • Patent Title: Methods for detecting and suppressing alignment errors caused by fusion events Jun. 03, 2025
  • Patent Title: Gene mutations and copy number alterations of egfr, kras and met Jun. 03, 2025
  • Patent Title: Methods and systems for detecting genetic variants Jun. 03, 2025
  • Patent Title: Methods and systems for analyzing nucleic acid molecules May. 27, 2025
  • Patent Title: Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage May. 06, 2025
  • Patent Title: Computational modeling of loss of function based on allelic frequency Apr. 29, 2025
  • Patent Title: Method for the detection of cancer Jun. 06, 2023
  • Patent Title: Methods and systems for detecting genetic variants Mar. 20, 2018
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Feb. 27, 2018
  • Patent Title: Methods for multi-resolution analysis of cell-free nucleic acids Dec. 26, 2017
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Dec. 12, 2017
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Dec. 05, 2017
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Oct. 17, 2017
  • Patent Title: Systems and methods to detect rare mutations and copy number variation Mar. 21, 2017
  • Patent Title: Method for the detection of cancer Nov. 12, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to GH from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
GH News

Recent insights relating to GH

CNBC Recommendations

Recent picks made for GH stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GH

GH Analyst Ratings

GH Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
GH Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $GH stock a Buy, Sell, or Hold?

  • What is the price target for $GH stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

GH Top Shareholders
Shareholder
Shares Held
GH Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $GH stock?

  • Who owns the most shares of $GH stock?

  • What funds own $GH stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

GH Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view GH Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About GH

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

  • Address Palo Alto, CA
  • Market Cap 23.8 billion
  • Employees 2,506
  • Industrial Classification Services-Medical Laboratories

Guardant Health, Inc. Common Stock (GH) Historical Stock Prices

Guardant Health, Inc. Common Stock (GH) closed at $177.25 on September 25, 2026. Over the past year its adjusted close ranged from $60.03 to $183.10. Daily prices go back to October 4, 2018, 2,003 trading days in all.

  • 1 month+3.70%
  • 3 months+18.78%
  • Year to date+73.54%
  • 1 year+194.53%
  • 3 years+587.02%
  • 5 years+38.05%
  • Max+450.47%
See every congressional and insider trade on the GH price chart

Quiver Premium charts GH's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 25, 2026 178.50 179.97 174.50 177.25 177.25 1,578,716
Sep 24, 2026 174.05 181.79 173.50 176.45 176.45 2,571,950
Sep 23, 2026 176.21 179.35 174.17 176.31 176.31 1,432,142
Sep 22, 2026 172.40 179.43 170.50 177.16 177.16 2,226,443
Sep 21, 2026 181.37 181.37 172.86 173.87 173.87 2,623,995
Sep 18, 2026 183.00 183.50 175.62 179.38 179.38 3,080,785
Sep 17, 2026 177.49 183.51 175.45 183.10 183.10 1,858,760
Sep 16, 2026 175.00 179.39 173.82 174.90 174.90 1,523,660
Sep 15, 2026 168.25 179.30 167.00 175.65 175.65 2,852,686
Sep 14, 2026 156.55 168.15 155.78 167.84 167.84 1,493,187
Sep 11, 2026 160.13 161.40 156.28 157.38 157.38 695,946
Sep 10, 2026 159.52 164.17 156.32 159.03 159.03 1,055,760
Sep 9, 2026 161.26 167.98 159.94 162.78 162.78 1,115,819
Sep 8, 2026 166.11 166.69 160.25 160.98 160.98 2,039,119
Sep 4, 2026 160.00 164.84 154.00 161.41 161.41 2,402,454
Sep 3, 2026 164.09 166.42 159.59 161.04 161.04 1,190,892
Sep 2, 2026 163.79 168.97 157.35 163.06 163.06 1,757,228
Sep 1, 2026 158.50 165.63 156.32 164.41 164.41 2,437,498
Aug 31, 2026 160.01 162.14 155.62 159.02 159.02 1,857,131
Aug 28, 2026 166.35 169.60 160.23 161.50 161.50 1,821,582
Aug 27, 2026 170.94 173.10 168.19 168.52 168.52 1,518,063
Aug 26, 2026 164.71 173.17 164.29 170.92 170.92 2,011,109
Aug 25, 2026 164.53 167.90 161.22 164.92 164.92 1,188,364
Aug 24, 2026 164.62 167.48 162.00 163.18 163.18 2,212,301
Aug 21, 2026 167.25 170.85 165.01 170.69 170.69 1,916,804
Aug 20, 2026 161.55 171.74 161.55 167.88 167.88 2,549,392
Aug 19, 2026 165.51 168.73 159.46 163.34 163.34 2,386,674
Aug 18, 2026 160.72 164.26 158.81 160.12 160.12 1,202,371
Aug 17, 2026 156.45 162.96 155.00 161.67 161.67 4,858,563
Aug 14, 2026 157.93 159.71 156.21 157.21 157.21 2,564,787
Aug 13, 2026 165.86 166.04 158.93 159.54 159.54 2,800,255
Aug 12, 2026 165.89 168.37 162.65 165.11 165.11 1,224,812
Aug 11, 2026 166.44 168.90 163.50 165.09 165.09 1,302,562
Aug 10, 2026 167.90 171.92 165.16 167.21 167.21 1,521,596
Aug 7, 2026 161.76 169.20 160.00 168.48 168.48 2,193,758
Aug 6, 2026 160.43 162.50 157.11 157.58 157.58 1,513,665
Aug 5, 2026 160.00 164.91 159.00 163.18 163.18 2,396,897
Aug 4, 2026 162.64 163.05 157.02 159.79 159.79 2,185,374
Aug 3, 2026 158.46 163.99 155.05 158.83 158.83 2,016,392
Jul 31, 2026 162.50 176.58 160.01 161.99 161.99 4,584,138
Jul 30, 2026 146.13 155.55 145.46 152.35 152.35 2,734,442
Jul 29, 2026 143.62 148.59 140.86 144.07 144.07 2,743,583
Jul 28, 2026 145.41 147.69 141.33 143.62 143.62 1,579,712
Jul 27, 2026 147.33 151.00 143.62 145.47 145.47 1,292,965
Jul 24, 2026 150.20 152.38 145.49 147.33 147.33 1,885,047
Jul 23, 2026 149.75 154.09 149.10 150.20 150.20 1,113,200
Jul 22, 2026 150.94 152.19 147.65 150.75 150.75 1,102,981
Jul 21, 2026 147.33 153.01 144.85 152.29 152.29 1,497,479
Jul 20, 2026 156.54 156.54 147.69 148.07 148.07 2,522,433
Jul 17, 2026 152.73 157.33 149.78 155.87 155.87 1,997,111
Jul 16, 2026 163.29 164.85 154.21 155.00 155.00 2,820,025
Jul 15, 2026 160.98 164.98 160.69 162.96 162.96 1,549,260
Jul 14, 2026 160.75 163.52 158.35 160.11 160.11 1,345,206
Jul 13, 2026 158.20 160.79 155.50 158.40 158.40 1,776,021
Jul 10, 2026 163.93 164.08 156.87 160.05 160.05 1,976,542
Jul 9, 2026 154.40 170.87 152.64 164.08 164.08 3,850,349
Jul 8, 2026 159.29 160.90 155.75 156.17 156.17 3,335,446
Jul 7, 2026 168.03 169.27 162.58 162.92 162.92 2,477,363
Jul 6, 2026 174.08 174.08 165.54 168.82 168.82 2,171,329
Jul 2, 2026 171.96 171.99 166.74 167.98 167.98 3,455,312
Jul 1, 2026 160.75 172.60 156.16 170.77 170.77 6,709,305
Jun 30, 2026 151.92 152.72 148.29 150.03 150.03 3,380,920
Jun 29, 2026 150.00 153.95 148.46 153.74 153.74 2,730,608
Jun 26, 2026 145.61 151.85 144.27 149.22 149.22 18,771,297
Jun 25, 2026 137.85 145.84 137.50 142.94 142.94 2,547,297
Jun 24, 2026 133.16 141.07 132.59 136.96 136.96 3,857,140
Jun 23, 2026 128.67 134.75 127.61 130.83 130.83 1,931,997
Jun 22, 2026 131.16 132.07 125.12 128.83 128.83 1,444,663
Jun 18, 2026 132.48 134.00 130.19 131.78 131.78 3,409,023
Jun 17, 2026 127.34 130.79 125.00 129.11 129.11 2,118,855
Jun 16, 2026 130.19 133.11 126.77 127.34 127.34 2,672,704
Jun 15, 2026 135.00 135.00 128.53 129.82 129.82 1,649,050
Jun 12, 2026 133.15 133.66 128.50 131.62 131.62 1,511,450
Jun 11, 2026 132.35 133.37 128.50 130.90 130.90 1,502,610
Jun 10, 2026 130.00 133.31 128.46 130.70 130.70 1,797,499
Jun 9, 2026 125.27 130.36 122.76 130.12 130.12 2,258,295
Jun 8, 2026 128.22 132.00 123.92 124.89 124.89 2,213,894
Jun 5, 2026 133.00 133.34 124.91 125.61 125.61 3,345,530
Jun 4, 2026 128.83 134.28 127.39 133.06 133.06 2,014,340
Jun 3, 2026 129.87 129.87 125.50 127.03 127.03 2,111,878
Jun 2, 2026 131.88 131.88 125.51 130.17 130.17 2,089,188
Jun 1, 2026 127.00 130.44 124.81 129.14 129.14 2,414,050
May 29, 2026 133.22 133.97 128.31 129.69 129.69 3,513,787
May 28, 2026 128.43 133.71 124.60 133.22 133.22 2,997,272
May 27, 2026 123.95 128.00 118.81 127.51 127.51 3,407,993
May 26, 2026 118.95 120.35 115.30 119.85 119.85 1,983,797
May 22, 2026 119.06 120.15 116.81 118.95 118.95 2,819,648
May 21, 2026 113.44 121.01 111.20 118.01 118.01 4,934,818
May 20, 2026 100.84 115.08 100.48 114.97 114.97 4,471,767
May 19, 2026 95.07 99.05 93.38 98.19 98.19 1,543,387
May 18, 2026 95.96 97.48 93.29 95.66 95.66 1,218,307
May 15, 2026 97.31 98.00 92.50 94.92 94.92 1,771,436
May 14, 2026 98.20 99.54 96.04 98.66 98.66 1,287,932
May 13, 2026 99.14 99.14 95.60 98.47 98.47 1,640,343
May 12, 2026 96.94 100.73 95.00 99.94 99.94 2,547,024
May 11, 2026 95.95 97.54 94.47 96.71 96.71 2,027,743
May 8, 2026 96.57 98.50 89.07 95.70 95.70 3,186,826
May 7, 2026 92.81 93.90 88.89 92.26 92.26 2,403,799
May 6, 2026 89.83 92.81 88.10 92.25 92.25 1,682,902
May 5, 2026 91.87 93.00 87.57 89.52 89.52 1,378,579
May 4, 2026 87.08 92.19 87.08 91.17 91.17 1,429,619
May 1, 2026 87.66 89.19 85.64 87.60 87.60 1,109,273
Apr 30, 2026 84.00 87.24 79.01 87.08 87.08 2,708,422
Apr 29, 2026 82.97 83.99 79.63 83.41 83.41 2,441,480
Apr 28, 2026 86.04 86.60 82.07 83.09 83.09 2,801,345
Apr 27, 2026 88.77 91.18 87.11 88.50 88.50 1,503,732
Apr 24, 2026 88.23 91.01 86.76 88.91 88.91 1,235,871
Apr 23, 2026 88.55 89.25 83.19 87.87 87.87 1,656,317
Apr 22, 2026 91.72 92.22 87.64 89.56 89.56 1,895,441
Apr 21, 2026 91.07 95.18 90.28 90.36 90.36 2,471,005
Apr 20, 2026 90.45 92.99 90.00 91.07 91.07 2,050,888
Apr 17, 2026 86.64 91.83 85.33 90.36 90.36 2,541,372
Apr 16, 2026 84.83 86.75 83.39 85.70 85.70 1,984,246
Apr 15, 2026 86.67 88.20 84.32 84.86 84.86 1,478,249
Apr 14, 2026 83.04 86.97 83.03 86.40 86.40 1,972,809
Apr 13, 2026 78.71 82.52 78.67 82.21 82.21 2,893,211
Apr 10, 2026 87.11 88.41 74.55 78.60 78.60 6,406,850
Apr 9, 2026 91.83 92.40 87.12 87.17 87.17 1,815,434
Apr 8, 2026 96.47 99.00 91.80 92.84 92.84 1,690,731
Apr 7, 2026 89.87 93.33 88.75 93.30 93.30 2,250,324
Apr 6, 2026 92.68 93.26 89.48 89.66 89.66 1,066,585
Apr 2, 2026 87.67 94.02 86.42 93.83 93.83 1,744,127
Apr 1, 2026 96.30 96.30 90.93 91.15 91.15 1,655,602
Mar 31, 2026 88.10 92.91 87.75 92.37 92.37 3,001,226
Mar 30, 2026 85.01 87.41 84.60 86.20 86.20 2,072,304
Mar 27, 2026 87.24 88.41 83.45 84.61 84.61 2,156,800
Mar 26, 2026 85.55 89.19 85.35 88.10 88.10 1,617,124
Mar 25, 2026 85.00 89.26 84.51 86.58 86.58 2,149,319
Mar 24, 2026 85.05 85.93 82.39 83.59 83.59 1,746,200
Mar 23, 2026 87.56 88.31 84.71 84.96 84.96 1,506,835
Mar 20, 2026 88.74 89.11 84.42 85.18 85.18 2,401,291
Mar 19, 2026 86.63 90.28 84.78 89.08 89.08 1,241,100
Mar 18, 2026 88.09 89.85 86.93 87.27 87.27 1,791,023
Mar 17, 2026 86.93 89.06 86.88 88.75 88.75 1,167,270
Mar 16, 2026 87.21 88.45 86.06 87.18 87.18 1,385,381
Mar 13, 2026 84.77 88.27 84.77 85.49 85.49 2,443,982
Mar 12, 2026 86.33 87.21 82.26 84.02 84.02 3,016,171
Mar 11, 2026 89.50 90.22 87.55 88.03 88.03 1,599,715
Mar 10, 2026 91.72 92.72 89.39 90.49 90.49 1,373,083
Mar 9, 2026 91.01 92.11 88.29 91.20 91.20 1,712,244
Mar 6, 2026 90.01 93.00 89.00 91.20 91.20 1,272,484
Mar 5, 2026 92.30 96.52 90.56 92.58 92.58 1,538,279
Mar 4, 2026 94.50 96.17 93.00 93.02 93.02 1,070,795
Mar 3, 2026 90.09 95.56 88.21 93.30 93.30 2,133,437
Mar 2, 2026 92.03 93.83 90.54 92.23 92.23 1,886,662
Feb 27, 2026 95.75 96.98 92.09 93.90 93.90 1,924,707
Feb 26, 2026 95.59 99.06 93.23 97.97 97.97 1,852,225
Feb 25, 2026 96.31 97.44 94.04 95.27 95.27 1,578,328
Feb 24, 2026 95.42 98.69 94.56 95.40 95.40 1,935,971
Feb 23, 2026 101.66 103.58 93.79 94.42 94.42 3,247,564
Feb 20, 2026 108.00 113.78 99.21 103.10 103.10 5,102,269
Feb 19, 2026 106.61 108.85 104.90 106.38 106.38 1,682,340
Feb 18, 2026 108.47 110.46 106.40 107.42 107.42 1,206,292
Feb 17, 2026 104.00 109.19 102.00 107.11 107.11 1,961,345
Feb 13, 2026 102.90 106.42 102.75 104.85 104.85 1,046,562
Feb 12, 2026 108.00 108.51 100.28 102.76 102.76 2,006,144
Feb 11, 2026 106.30 107.67 100.26 107.58 107.58 1,759,360
Feb 10, 2026 105.58 107.69 104.53 105.03 105.03 1,177,170
Feb 9, 2026 101.08 106.73 99.50 105.34 105.34 1,555,380
Feb 6, 2026 100.77 102.70 97.52 101.85 101.85 2,271,773
Feb 5, 2026 105.27 107.76 97.88 98.36 98.36 5,320,701
Feb 4, 2026 113.05 113.99 102.21 106.15 106.15 3,837,763
Feb 3, 2026 115.95 118.00 111.33 113.05 113.05 1,638,721
Feb 2, 2026 113.68 116.27 112.41 114.90 114.90 1,734,118
Jan 30, 2026 111.59 114.97 108.74 114.04 114.04 2,021,475
Jan 29, 2026 107.68 110.48 105.78 110.48 110.48 1,167,265
Jan 28, 2026 114.86 115.25 109.25 109.73 109.73 1,706,182
Jan 27, 2026 114.00 117.00 113.53 114.59 114.59 1,295,272
Jan 26, 2026 114.15 117.73 113.02 114.74 114.74 1,115,783
Jan 23, 2026 116.50 118.29 113.67 114.75 114.75 1,466,406
Jan 22, 2026 116.41 120.74 115.95 117.28 117.28 3,002,629
Jan 21, 2026 115.10 116.41 110.31 115.75 115.75 2,268,847
Jan 20, 2026 110.50 114.97 109.11 114.87 114.87 1,926,709
Jan 16, 2026 111.98 115.54 110.09 112.14 112.14 2,120,492
Jan 15, 2026 108.93 112.53 108.39 111.98 111.98 1,546,704
Jan 14, 2026 106.87 109.08 104.66 108.60 108.60 1,390,354
Jan 13, 2026 107.99 108.38 103.81 106.89 106.89 1,511,152
Jan 12, 2026 113.00 113.91 103.80 107.57 107.57 2,358,490
Jan 9, 2026 108.17 112.40 106.97 110.17 110.17 2,412,066
Jan 8, 2026 109.01 111.50 106.42 108.74 108.74 1,801,101
Jan 7, 2026 112.66 113.91 108.60 109.93 109.93 2,607,658
Jan 6, 2026 101.92 112.44 101.92 112.33 112.33 4,490,706
Jan 5, 2026 101.10 103.55 97.31 101.87 101.87 2,909,456
Jan 2, 2026 102.30 102.80 100.76 101.74 101.74 1,093,311
Dec 31, 2025 100.76 102.72 100.58 102.14 102.14 1,026,320
Dec 30, 2025 101.89 101.95 99.82 100.60 100.60 987,279
Dec 29, 2025 102.52 103.21 100.70 101.39 101.39 910,687
Dec 26, 2025 102.28 104.75 101.50 102.98 102.98 1,042,484
Dec 24, 2025 101.87 103.00 101.39 102.38 102.38 581,198
Dec 23, 2025 100.76 103.17 100.00 102.50 102.50 1,485,370
Dec 22, 2025 100.93 102.14 99.77 101.34 101.34 1,375,707
Dec 19, 2025 96.64 100.07 96.51 99.74 99.74 3,451,704
Dec 18, 2025 98.54 99.82 96.28 97.10 97.10 3,042,097
Dec 17, 2025 101.46 101.46 96.95 97.47 97.47 1,912,710
Dec 16, 2025 102.01 103.00 97.17 100.00 100.00 3,264,345
Dec 15, 2025 104.12 105.01 102.20 102.67 102.67 1,967,701
Dec 12, 2025 103.52 103.52 100.47 102.07 102.07 1,508,251
Dec 11, 2025 104.36 104.37 100.21 101.38 101.38 1,376,567
Dec 10, 2025 103.21 105.67 102.30 102.62 102.62 1,930,468
Dec 9, 2025 104.03 106.00 101.94 103.21 103.21 1,424,937
Dec 8, 2025 102.60 106.15 102.07 104.17 104.17 1,881,206
Dec 5, 2025 108.84 108.84 100.67 102.02 102.02 3,757,390
Dec 4, 2025 106.01 109.59 105.68 108.52 108.52 1,905,610
Dec 3, 2025 104.45 107.19 103.47 105.96 105.96 1,592,743
Dec 2, 2025 106.62 107.47 103.36 103.87 103.87 1,543,293
Dec 1, 2025 107.92 108.12 104.57 105.22 105.22 1,677,165
Nov 28, 2025 108.81 108.81 106.48 108.42 108.42 694,732
Nov 26, 2025 108.76 109.81 106.67 107.79 107.79 1,595,695
Nov 25, 2025 112.42 112.42 108.52 108.81 108.81 2,860,791
Nov 24, 2025 105.79 111.91 104.35 111.25 111.25 2,835,766
Nov 21, 2025 99.75 108.06 98.23 105.42 105.42 3,348,398
Nov 20, 2025 103.50 110.00 100.03 100.30 100.30 5,522,772
Nov 19, 2025 95.88 105.27 95.01 99.55 99.55 4,720,984
Nov 18, 2025 95.84 97.67 94.05 95.57 95.57 1,530,408
Nov 17, 2025 94.49 97.45 93.98 96.48 96.48 1,523,826
Nov 14, 2025 91.21 95.78 90.44 94.37 94.37 1,732,468
Nov 13, 2025 96.82 98.17 93.51 94.13 94.13 2,152,322
Nov 12, 2025 98.36 99.73 95.26 97.84 97.84 2,329,582
Nov 11, 2025 96.78 99.31 96.75 97.71 97.71 1,900,647
Nov 10, 2025 98.00 101.57 96.45 97.92 97.92 2,825,739
Nov 7, 2025 95.08 96.77 92.54 96.72 96.72 2,745,617
Nov 6, 2025 95.01 97.51 89.68 96.25 96.25 4,021,540
Nov 5, 2025 92.75 95.24 88.88 95.05 95.05 9,810,345
Nov 4, 2025 93.40 100.22 93.05 98.14 98.14 3,066,084
Nov 3, 2025 94.07 99.23 92.57 98.92 98.92 2,686,268
Oct 31, 2025 91.39 93.66 88.68 93.02 93.02 4,053,797
Oct 30, 2025 89.99 95.88 88.22 92.41 92.41 11,095,411
Oct 29, 2025 69.17 73.15 68.02 72.27 72.27 4,725,062
Oct 28, 2025 70.85 70.85 68.33 69.58 69.58 1,933,647
Oct 27, 2025 72.56 73.31 70.01 70.85 70.85 1,971,529
Oct 24, 2025 70.28 72.70 69.83 72.15 72.15 2,469,417
Oct 23, 2025 67.82 69.38 66.59 69.35 69.35 2,065,646
Oct 22, 2025 69.23 69.51 66.72 68.03 68.03 1,959,151
Oct 21, 2025 70.12 70.33 67.04 67.51 67.51 2,548,615
Oct 20, 2025 65.96 70.28 65.96 70.20 70.20 2,446,007
Oct 17, 2025 66.95 67.09 64.00 65.46 65.46 1,685,483
Oct 16, 2025 64.61 68.23 64.58 67.47 67.47 2,967,847
Oct 15, 2025 63.09 65.27 62.98 64.19 64.19 1,701,865
Oct 14, 2025 61.46 63.77 61.00 62.56 62.56 1,430,959
Oct 13, 2025 64.56 65.23 61.33 61.73 61.73 2,026,032
Oct 10, 2025 66.57 66.57 63.87 64.22 64.22 2,171,352
Oct 9, 2025 65.15 66.50 64.90 65.26 65.26 1,175,132
Oct 8, 2025 64.07 66.03 63.78 65.32 65.32 1,594,533
Oct 7, 2025 63.27 64.19 61.70 63.44 63.44 1,431,164
Oct 6, 2025 63.10 65.19 62.95 63.38 63.38 1,996,982
Oct 3, 2025 61.91 63.61 61.13 62.84 62.84 1,825,940
Oct 2, 2025 62.60 63.00 60.45 61.46 61.46 2,086,252
Oct 1, 2025 62.48 63.63 61.67 62.65 62.65 1,751,300
Sep 30, 2025 61.98 62.55 61.32 62.48 62.48 1,917,838
Sep 29, 2025 60.03 62.78 59.63 61.99 61.99 2,654,540
Sep 26, 2025 60.18 60.71 59.03 60.03 60.03 2,484,591
Sep 25, 2025 59.37 63.05 58.73 60.18 60.18 4,712,313

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Guardant Health, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at GH, per a recent SEC DEF 14A filing. We estimate that the median employee at Guardant Health, Inc. is paid $215,141.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation